CLINICAL STAGE II GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AJCC V8
Clinical trials for CLINICAL STAGE II GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE II GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE II GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation approach may spare heart and lungs in esophageal cancer patients
Disease control Recruiting nowThis study compares two radiation methods for people with stage I to IVA esophageal cancer: proton beam therapy and standard photon radiation (IMRT). The goal is to see which one helps patients live longer and causes fewer serious heart and lung side effects. About 300 adults wil…
Matched conditions: CLINICAL STAGE II GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New combo before surgery aims to boost esophageal cancer outcomes
Disease control Recruiting nowThis study is for people with stage I to III esophageal or gastroesophageal junction cancer who are scheduled for surgery. It tests whether giving a shorter, higher-dose course of radiation along with the chemotherapy drugs FOLFOX before surgery can kill more tumor cells and caus…
Matched conditions: CLINICAL STAGE II GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC